Eric Lefkofsky Unveils New Tempus Mobile App, Tempus Labs

Eric Lefkofsky is an entrepreneur based out of Chicago, IL. For the past several years, Lefkofsky has made an impact in the technological field thanks to his ability to expertly work with data collection and analytics. Now, Lefkofsky is taking his natural skills and talent and putting it toward developing the company that he co-founded just a few years ago, Tempus. Tempus is a business that is focused primarily on the collection and subsequent analysis of clinical and molecular data. The goal of Tempus is to provide physicians with the genomic and clinical data that they need in order to find appropriate treatment routines for patients fighting cancer. Now, Lefkofsky and Tempus are unveiling a brand new mobile application to make that task even easier: Tempus Labs.

Tempus Labs is available on both the iOS App Store and the Google Play store. The application had been going through stress testing for several months now by being put into the hands of capable physicians throughout the nation. Now, with a full release on the docket, Tempus Labs will be usable by physicians who are in possession of the Tempus CLIA/CAP Validated Assays, of which there are three: xT (595 genes), xO (1714 genes); and xE (whole exome). The application was developed by Lefkofsky in conjunction with the COO of Tempus, Ryan Fukushima. The application will give physicians the ability to access the data that they need no matter where they are at, so long as their mobile app is installed and accessible. The application will go a long way toward giving physicians and their patients all of the necessary tools to set up a regiment that is effective for the personalized treatment of cancer.

The announcement of Tempus Labs comes on the heels of Tempus raising an incredible $110 million in Series E funding. Tempus has been growing exponentially over the last year and the odds are good that they’ll continue this rate of pace into the foreseeable future. Tempus will be another addition to Lefkofsky’s legacy of Chicago-made startups that have fundamentally changed the way that we live our lives.

About Eric Lefkofsky:

Dr. Mark Mofid Puts Patients Before Profits

In the world of cosmetic elective surgery trust is a very important factor. Much like a tattoo, even the simplest cosmetic operation is something the patient will live with for the rest of their lives. Therefore, it is important that the patient be able to trust their practitioner, and for that practitioner to be an expert. This is why Dr. Mark Mofid is one of the leading names in the industry. A graduate of both Harvard and Johns Hopkins, Mofid is an expert. His knowledge of medical procedures is vast, as it his experience. But it is his reputation for putting patients before profits that draws most to him.

Dr. Mark Mofid is an innovator. He refuses to perform operations that are unsafe, and is constantly researching ways to operate better. His methods create the safest procedures that use the least amount of tissue. He is known to refuse operation that are unnecessary, even if the patient is willing to pay more. It is his goal that the patient get the best service, the best treatment, and best outcome from their surgery. His methods are completely supported by science, over detailed, and use his full understanding of the body’s muscle systems. At present he is the leading expert in the field of gluteal augmentation, having developed the safest most natural looking implants on the market. His research into the gluteal augmentation industry have revolutionized the process, making it safer and far more successful. As with any operation Dr. Mark Mofid is always looking for ways to accomplish the task better than before. He is a firm believer development.

For Dr. Mark Mofid trust is the highest commodity he deals with. His patients know that they will be cared for, and will receive the best treatment. In addition to his practice, and serving as surgeon for numerous hospitals around La Jolla, Dr. Mark Mofid also gives back to the community. He sponsors numerous charities, and provides top care for patients in need of reconstructive surgery.